IndustriesA-sharesKey event

China's Ten Ministries Issue 15th Five-Year Plan for Pharmaceutical Industry

Published: Updated: By 24TopNews Editorial Desk

China's Ministry of Industry and Information Technology and nine other departments issued the 15th Five-Year Plan for the pharmaceutical industry on September 18, 2026. The plan calls for stronger original innovation capacity, focusing on major infectious diseases, major chronic diseases, rare diseases and pediatric medicines, and accelerating the upgrade of innovative drug and device research toward first-in-class, breakthrough and disruptive advances.

On September 18, 2026, the Ministry of Industry and Information Technology and nine other departments issued the 15th Five-Year Plan for the Development of the Pharmaceutical Industry.

The plan calls for strengthening original innovation capacity, focusing on key areas such as major infectious diseases, major chronic diseases, rare diseases and pediatric medicines, reinforcing the principal role of enterprises in innovation, and accelerating the upgrade of China's innovative drug and medical device research and development toward first-in-class, breakthrough and disruptive advances.

The plan also calls for supporting pharmaceutical enterprises in targeting frontier medical science and technology to develop a batch of first-in-class (FIC) drugs with new targets, new mechanisms and new drug types, as well as best-in-class (BIC) drugs, and to accelerate the research, development and application of a batch of frontier and leading high-end medical devices.

24TOPNEWS IMPACT INTELLIGENCE

Why this event matters

The event has a measured impact on 5 industrys. The strongest current signal is positive for Biotechnology, with intensity 75/100 and 85% confidence over a medium term horizon.

Healthcare · 13.3

Biotechnology

Direction
positive
Intensity
75
Confidence
85%
Horizon
Medium term
Effective impact +50
Healthcare · 13.1

Pharmaceuticals

Direction
positive
Intensity
72
Confidence
85%
Horizon
Medium term
Effective impact +48
Healthcare · 13.5

Medical Equipment

Direction
positive
Intensity
70
Confidence
82%
Horizon
Medium term
Effective impact +45
Healthcare · 13.15

Pharmaceutical R&D Services

Direction
positive
Intensity
65
Confidence
75%
Horizon
Medium term
Effective impact +38
Chemicals & Materials · 3.5

Pharmaceutical Chemicals

Direction
mixed
Intensity
50
Confidence
65%
Horizon
Medium term
Effective impact 0

Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.